Table 3.

Proportion of patients who restarted systemic treatment after IAS injection

	6 months*	12 months**
Prior biologic use	0.68 (15/22)	0.85 (17/20)
No biologic	0.24 (4/17)	0.40 (4/10)
Total	0.49 (19/39)	0.7 (21/30)

*p < 0.01, ** p < 0.05